Dolsten Mikael, director at Agilent Technologies ($A), made one open market sale of company shares in the last year, totaling $389,511 on December 1, 2025. This ranks him 7,001st among nearly 12,000 insiders by sale value, well below the $8.6 million average across 6.4 transactions each. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | AGILENT TECHNOLOGIES, INC. | $A | Dolsten Mikael | Director | A | Common Stock | 2158 | $111.75 | 7,138.2100 | 285,000,000 | 43.33% | 0.00% |
| Feb. 27, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Dolsten Mikael | Director | A | Stock Option (Right to Buy) | 24135 | $20.96 | 24,135.0000 | 130,067,000 | 9999.99% | 0.02% |
| Feb. 27, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Dolsten Mikael | Director | A | Common Stock | 14312 | $0.00 | 14,312.0000 | 130,067,000 | 9999.99% | 0.01% |
| Dec. 1, 2025 | AGILENT TECHNOLOGIES, INC. | $A | Dolsten Mikael | Director | S | Common Stock | 2600 | $149.81 | 4,973.0280 | 285,000,000 | 34.33% | 0.00% |
| June 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Dolsten Mikael | Not found | A | Common Stock | 30000 | $0.00 | 44,220.0000 | 94,807,773 | 210.97% | 0.03% |
| March 5, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Dolsten Mikael | Not found | J | Common Stock | 14220 | $0.00 | 14,220.0000 | 94,807,773 | 9999.99% | 0.01% |
| March 14, 2025 | AGILENT TECHNOLOGIES, INC. | $A | Dolsten Mikael | Director | A | Common Stock | 1819 | $121.18 | 7,549.9360 | 291,000,000 | 31.74% | 0.00% |
| Sept. 12, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | D | Stock Appreciation Rights | 137760 | $0.00 | 0.0000 | 5,709,000,000 | 100.00% | 0.00% |
| Sept. 12, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | D | Stock Appreciation Rights | 126794 | $0.00 | 0.0000 | 5,709,000,000 | 100.00% | 0.00% |
| Sept. 12, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | A | Stock Appreciation Rights | 126794 | $0.00 | 126,794.0000 | 5,709,000,000 | 9999.99% | 0.00% |
| Sept. 12, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | A | Stock Appreciation Rights | 137760 | $0.00 | 137,760.0000 | 5,709,000,000 | 9999.99% | 0.00% |
| Sept. 9, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Dolsten Mikael | Not found | A | Stock Option (Right to Buy) | 27545 | $0.00 | 27,545.0000 | 84,009,004 | 9999.99% | 0.03% |
| Sept. 9, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Dolsten Mikael | Not found | A | Stock Option (Right to Buy) | 22988 | $0.00 | 22,988.0000 | 84,009,004 | 9999.99% | 0.03% |
| March 15, 2024 | AGILENT TECHNOLOGIES, INC. | $A | Dolsten Mikael | Director | A | Common Stock | 1678 | $147.48 | 5,711.1980 | 296,000,000 | 41.60% | 0.00% |
| Feb. 28, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | F | Common Stock | 21437 | $27.04 | 323,710.0000 | 5,709,000,000 | 6.21% | 0.00% |
| Feb. 27, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | A | Stock Appreciation Rights | 189867 | $0.00 | 189,867.0000 | 5,709,000,000 | 9999.99% | 0.00% |
| Feb. 27, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | A | Stock Appreciation Rights | 214880 | $0.00 | 214,880.0000 | 5,709,000,000 | 9999.99% | 0.00% |
| Feb. 23, 2024 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | F | Common Stock | 24822 | $27.76 | 345,147.0000 | 5,709,000,000 | 6.71% | 0.00% |
| Dec. 15, 2023 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | I | Phantom Stock Units | 37552 | $26.63 | 87,581.0000 | 5,733,000,000 | 75.06% | 0.00% |
| March 16, 2023 | AGILENT TECHNOLOGIES, INC. | $A | Dolsten Mikael | Director | A | Common Stock | 1658 | $136.82 | 4,018.0020 | 0 | 70.25% | 0.00% |
| Feb. 25, 2023 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | F | Common Stock | 37078 | $41.75 | 356,026.0000 | 5,733,000,000 | 9.43% | 0.00% |
| Feb. 23, 2023 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | A | Stock Appreciation Rights | 137760 | $0.00 | 137,760.0000 | 5,733,000,000 | 9999.99% | 0.00% |
| Feb. 23, 2023 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | A | Stock Appreciation Rights | 119894 | $0.00 | 119,894.0000 | 5,733,000,000 | 9999.99% | 0.00% |
| Feb. 22, 2023 | PFIZER INC | $PFE | Dolsten Mikael | President R&D | F | Common Stock | 32592 | $42.38 | 393,104.0000 | 5,733,000,000 | 7.66% | 0.00% |